Published on 30, Nov 2022

Base Healthcare Works to Help the 20MM Men in America with Low Testosterone

RALEIGH, N.C.--The launch of Base Healthcare comes at a time when 39% of men 45 years and older in America have hypogonadism. As more men struggle with symptoms of inadequate testosterone levels, Base Healthcare has begun its mission is to improve their outcomes and overall quality of life. To accomplish this, it is working to increase men’s understanding of testosterone deficiency, improve their foundational health, and help them to potentially avoid downstream diseases, such as type-2 diabetes, cardiovascular disease, and fatty liver disease. 

The founders of Base Healthcare, Shalin Shah and Himanshu Shah, state that central to the company’s programs will be education, beginning with information about commonly misunderstood symptoms that might indicate an individual is hypogonadal. While fatigue, low energy, weight gain, lower muscle mass, low libido, decreased bone density, depression, and anxiety can all point to other conditions, they are common indicators of testosterone deficiency. The company will also help the American public to understand the lifestyle factors that may contribute to hypogonadism. Through these efforts, Base Healthcare seeks to increase the number of men who are aware that they have hypogonadism and who take steps to optimize their testosterone levels.

The company has rolled out its three core services, including its men’s virtual health platform, its FDA-approved Oral Testosterone Therapy, and its patient-centered health coaching. Through the platform, Base Healthcare plans to provide each member with the ability to access and understand their health metrics in nutrition, sleep, stress, and exercise. The goal is that through the dashboard’s smartphone-based scanning technology, each person can monitor their health at any time, including their body composition, body circumference, blood pressure, respiration rate, and more.

Base Healthcare will also provide its members with certified clinicians who discuss lab results with members and determine if they are candidates for the company’s FDA-approved Oral Testosterone Therapy. The new treatment, approved in 2022, is meant to improve upon previous treatments, which while often effective, led to scarring or were visible or messy to use.

As Base Healthcare raises awareness of low testosterone and brings its new three-tier program to men and their families across the United States, it remains committed to turning the page on hypogonadism so that one day, its services will no longer be needed.

Base Healthcare is a men’s virtual health platform that focuses on foundational health and optimization using an FDA-approved oral testosterone therapy and patient-centered health coaching.